Topic: MS

High-efficacy DMTs for MS: the year in review

December 1, 2025  

Ocrelizumab use throughout the MS clinical course: highlights from ECTRIMS 2025

October 15, 2025  

Early use and long-term safety of ofatumumab: highlights from ECTRIMS 2025

October 7, 2025  

ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025

September 27, 2025  

ECTRIMS 2025 HIGHLIGHTS – FRIDAY, SEPTEMBER 26, 2025

September 26, 2025  

ECTRIMS 2025 HIGHLIGHTS – THURSDAY, SEPTEMBER 25, 2025

September 25, 2025  

ECTRIMS 2025 survey

September 4, 2025  

Baseline sNfL prognostic of disease activity in CIS

August 21, 2025  

CLINICAL CASES IN MS: A PATIENT CONSIDERING TREATMENT DISCONTINUATION

August 19, 2025  

CLINICAL CASES IN MS: A PATIENT WITH MRI LESIONS CONSISTENT WITH MS

July 22, 2025